Clinical Trials
174 trialsJADE
GlaxoSmithKline
ILLUMINE
Groupe Oncologie Radiotherapie Tete et Cou
MK-3475-689
Merck Sharp & Dohme LLC
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Canadian Cancer Trials Group
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Merus B.V.
SWOAR
All India Institute of Medical Sciences
LYSARI
Centre Leon Berard
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
M.D. Anderson Cancer Center
VERSATILE-003
PDS Biotechnology Corp.
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy
West China Hospital
INTERLINK-1
AstraZeneca
AcceleRET-Lung
Hoffmann-La Roche
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Eastern Cooperative Oncology Group
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
EMD Serono
Tumescence in HNC Skin Graft Reconstruction
University of California, Davis
KEYNOTE-412
Merck Sharp & Dohme LLC
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Radiation Therapy Oncology Group
LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Boehringer Ingelheim
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Shandong Cancer Hospital and Institute
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Systematic Oral Education for Prevention of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
West China Hospital
Head and Neck Cancer Study Project in the Geriatric Population
Brown University
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
Incyte Corporation
PRIMO
Radboud University Medical Center
UPFRONT-NECK
Insel Gruppe AG, University Hospital Bern
UPGRADE-RT
Radboud University Medical Center
BURAN
Adlai Nortye Biopharma Co., Ltd.
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract
Centre Antoine Lacassagne
Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy
University of California, San Francisco
Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible
Sunnybrook Health Sciences Centre
MK-3475-048
Merck Sharp & Dohme LLC
MOIO
UNICANCER
SHORT-OPC
Centre hospitalier de l'Université de Montréal (CHUM)
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
Fudan University
REACH
Groupe Oncologie Radiotherapie Tete et Cou
NICAP
Eurofarma Laboratorios S.A.
SurVIC
All India Institute of Medical Sciences, Jodhpur
ARTFORCE
The Netherlands Cancer Institute
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
Rakuten Medical, Inc.
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
INDUCE-4
GlaxoSmithKline
stREnGTH
University Hospital, Ghent
INDUCE-3
GlaxoSmithKline
OPEN
Irish Research Radiation Oncology Group
HiLo
University College, London
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients
Galera Therapeutics, Inc.
CheckMate 651
Bristol-Myers Squibb